Role of aromatase inhibitor in ovulation induction in patients with poor response to clomiphene citrate

Journal of Obstetrics and Gynaecology Research

Volumn 32, Issue 5, 2006, Pages 502-506

  Begum, Mosammat R ^a,e   Quadir, Ehsan ^b   Begum, Anowara ^a   Begum, Rowsan A ^c   Begum, Momtaz ^d  

^a DHAKA MEDICAL COLLEGE HOSPITAL   (Bangladesh)

^b SIR SALIMULLAH MEDICAL COLLEGE   (Bangladesh)

^c Holy Family Red Crescent Medical College   (Bangladesh)

^d Bangladesh Medical College   (Bangladesh)

^e NONE   (Bangladesh)

Author keywords

Letrozole; Ovulation; Pregnancy

Indexed keywords

AROMATASE INHIBITOR; CLOMIFENE CITRATE; LETROZOLE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; ENDOMETRIUM CELL; FEMALE; FEMALE INFERTILITY; HUMAN; MENSTRUAL CYCLE; OUTCOME ASSESSMENT; OVARY CYCLE; OVARY FOLLICLE CELL; OVULATION INDUCTION; PATIENT COMPLIANCE; PATIENT REFERRAL; POPULATION; PREGNANCY RATE; TREATMENT DURATION;

ADULT; AROMATASE INHIBITORS; CLOMIPHENE; FEMALE; HUMANS; INFERTILITY, FEMALE; NITRILES; OVARIAN FOLLICLE; OVULATION INDUCTION; PREGNANCY; PROSPECTIVE STUDIES; TRIAZOLES;

EID: 33748806795     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2006.00434.x     Document Type: Article

References (26)

1. Dickey RP, Taylor SN, Curole DN, Rye PH, Pyrzak R. Incidence of spontaneous abortion in clomiphene pregnancies. Hum Reprod 1996; 11: 2623-2628.
2. Gorlitsky GA, Kase NG, Speroff L. Ovulation and pregnancy rates with clomiphene cirate. Obstet Gynaecol 1978; 51: 265-269.
3. Garcia J, Seegar-Jones G, Wentz AC. The use of clomiphene citrate. Fertl Steril 1977; 28: 707-717.
4. Hammond MG. Monitoring techniques for improved pregnancy rates during clomiphene ovulation induction. Fertil Steril 1984; 42: 499-508.
5. Gysler M, March CM, Mishell DR, Bailey EJ. A decade's experience with an individualized clomiphene treatment regimen including its effects on the postcoital test. Fertile Steril 1928; 37: 161-167.
6. Young SL, Opsahl MS, Fritz MA. Serum concentrations of enclomiphene and zuclomiphene across consecutive cycles of climiphene citrate therapy in anovulatory infertile women. Fertil Steril 1999; 71: 639-644.
7. Randall JM, Templeton A. Cervical mucus score and in vitro sperm mucus interaction in spontaneous and clomiphene citrate cycles. Fertil Steril 1991; 56: 465-468.
8. Gonen Y, Casoer RF. Sonographic determination of an adverse effect of clomiphene citrate on endometrial growth. Hum Reprod 1990; 5: 670-674.
9. Eden JA, Place J, Carter GD, Jones J, Alaghband-Zadeh J, Pawson ME. The effect of clomiphene citrate on follicular phase increase in endometrial thickness and uterine volume. Obstet Gynaecol 1989; 73: 187-190.
10. Opsahl MS, Robins ED, O'Connor DM, Scott RT, Fritz MA. Characteristics of gonadotropin response, follicular development, and endometrial growth and maturation across consecutive cycles of clomiphene citrate treatment. Fertil Steril 1996; 66: 533-539.
11. Mitwally MFM, Casper RF. Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Ferti Steril 2001; 75: 305-309.
12. Ariel W, McArdle CR, Reuwen A. Ultrasound in Infertility. In: Machelle M, Seibel MD (eds). Infertility a Comprehensive Text, 2nd edn. CT: Appleton & Lange Stamford, 1996; 447-492.
13. Okman KT, Kucuk M, Altaner S. Comparison of the effects of Letrozole and clomiphene citrate on ovarian follicles, endometrium and hormone levels in the rat. Fertil Steril 2003; 80: 1330-1332.
14. Erickson GF. Control of follicular development. In: Lobo RA, Mishell DR, Paulson RJ, Shoupe D (eds). Mishell's Textbook of Infertility Contraception and Reproductive Endocrinology, 4th edn. USA: Library of Congress cataloging-in-publication, 1997; 161-173.
15. Weil SJ, Vendola K, Zhou J et al. Aandrogen receptor controlled ovarian hyperstimulation in the primate ovary: cellular localization, regulation, and functional correlation. J Clin Endocrinol Metab 1998; 83: 2479-2485.
16. Weil S, Vendola K, Zhou J, Bondy CA. Androgen and follicle-stimulating hoemone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 1999; 84: 2951-2956.
17. Vendola K, Zhou J, Wang J, Famuyiwa OA, Bienre M, Bondy CA. Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primale ovary. Biol Reprod 1999; 61: 353-357.
18. Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. Androgen stimulate early stages of follicular growth in the primate ovary. J Clin Invest 1998; 101: 2622-2629.
19. Adashi E. Intraovarian regulation: the proposed role of insulin-like growth factors. Ann NY Acad Aci 1993; 687: 10-12.
20. Giudice LC. Insulin-like growth factors and ovarian follicular development. Endocr Rev 1992; 13: 641-669.
21. Yen SSC, Laughlin GA, Morales AJ. Interface between extra- and intra-ovarian factors in polycystic ovary syndrome (PCOS). Ann NY Acad Sci 1993; 687: 98-111.
22. Mitwally MFM, Casper RF. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders. Fertil Steril 2002; 77: 776-780.
23. Fisher SA, Reid RL, Vugt DA, Casper RF. A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women. Fertil Steril 2002; 78: 280-285.
24. Lamb HM, Adkins JC. Letrozole: a review of its use in postmenopausal women with advanced breast cancer. Drugs 1998; 56: 1125-1140.
25. Dowsett M, Jones A, Johnston SR, Jacobs S, Trunet P, Smith IE. In vivo measurement of aromatase inhibition by letrozole in postmenopausal women with breast cancer. Clin Cancer Res 1995; 1: 1511-1515.
26. Buzdar A, Howell A. Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer. Clin Cancer Res 2001; 7: 2620-2635.